Request Deal Involvement
Neurocrine Biosciences to invest $175m in Voyager Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Kendall Investor Relations
pr advisors
Verge Scientific Communications
or
Principals
bidder
NEUROCRINE BIOSCIENCES
target
VOYAGER THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite